The authors went even one step further and developed a novel ITGA5-antagonizing peptidomimetic (AV3) that could inhibit PSC activation and enhance the cytotoxic effects of gemcitabine in spheroid co-cultures of cancer cell lines with PSCs (Kuninty et al., 2019). Here, ITGA5 is linked to cancer.